Federated Hermes’s Applied Therapeutics APLT Stock Holding History

Federated Hermes’s Portfolio APLT Stock Details APLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-519	Closed	-$1K	–	2139
2022 Q1	$1K	Buy	+519	New	+$1.39K	﹤0.01%	2059
2020 Q3	–	Sell	-47,848	Closed	-$1.73M	–	2245
2020 Q2	$1.73M	Buy	47,848 +39,478	+472%	+$1.65M	﹤0.01%	1042
2020 Q1	$274K	Sell	8,370 -32,543	-80%	-$1.32M	﹤0.01%	1525
2019 Q4	$1.12M	Buy	+40,913	New	+$701K	﹤0.01%	1238

Other funds holding APLT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Federated Hermes's APLT Position: Q2 2022 in Review

Federated Hermes sold out of Applied Therapeutics (APLT) in Q2 2022, closing a stake of 519 shares — an estimated $1K sold.

Federated Hermes first reported a position in APLT in Q4 2019 and held it in 4 quarters. The position peaked at $1.73M in Q2 2020. 53 funds tracked by Wall St. Rank hold APLT as of Q2 2022.

Federated Hermes reported no remaining Applied Therapeutics position as of Q2 2022 after selling out during the quarter.
Federated Hermes sold 519 Applied Therapeutics shares in Q2 2022, an estimated $1K.
Federated Hermes first reported a position in Applied Therapeutics in Q4 2019 and held it in 4 quarters.
Federated Hermes's Applied Therapeutics position peaked at $1.73M in Q2 2020.
53 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.